Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype

Koichi Miyaki, Mitsuru Murata, Haruhito Kikuchi, Izumi Takei, Takeo Nakayama, Kiyoaki Watanabe, Kazuyuki Omae

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

This study aimed at assessing the effect of folic acid supplementation quantitatively in each MTHFR C677T genotype and considered the efficiency of tailor-made prevention of atherosclerosis. Study design was genotype-stratified, randomized, double-blind, placebo-controlled trials. The setting was a Japanese company in the chemical industry. Subjects were 203 healthy men after exclusion of those who took folic acid or drugs known to effect folic acid metabolism. Intervention was folic acid 1 mg/day p.o. for 3 months. The primary endpoint was plasma total homocysteine level (tHcy). In all three genotypes, there were significant tHcy decreases. The greatest decrease was in the TT homozygote [6.61 (3.47-9.76) μmol/l] compared with other genotypes [CC: 2.59 (1.81-3.36), CT: 2.64 (2.16-3.13)], and there was a significant trend between the mutated allele number and the decrease. The tHcy were significantly lowered in all the genotypes, but the amount of the decrease differed significantly in each genotype, which was observed at both 1 and 3 months. Using these time-series data, the largest benefit obtained by the TT homozygote was appraised as 2.4 times compared with the CC homozygote. Taking into account the high allele frequency of this SNP, this quantitative assessment should be useful when considering tailor-made prevention of atherosclerosis with folic acid.

Original languageEnglish
Pages (from-to)241-248
Number of pages8
JournalJournal of Human Genetics
Volume50
Issue number5
DOIs
Publication statusPublished - 2005 May 1

    Fingerprint

Keywords

  • Arteriosclerosis
  • Dietary supplements
  • Folic acid
  • Homocysteine
  • Methylenetetrahydrofolate reductase (NADPH2)
  • Polymorphism

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this